Geode Capital Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Sell |
84,895
-1,416
| -2% | -$3.38K | ﹤0.01% | 3865 |
|
|
2025
Q1 | $371K | Buy |
86,311
+9,712
| +13% | +$41.8K | ﹤0.01% | 3652 |
|
|
2024
Q4 | $659K | Buy |
76,599
+55,149
| +257% | +$474K | ﹤0.01% | 3517 |
|
|
2024
Q3 | $365K | Buy |
21,450
+1,346
| +7% | +$22.9K | ﹤0.01% | 3702 |
|
|
2024
Q2 | $304K | Sell |
20,104
-13,166
| -40% | -$199K | ﹤0.01% | 3761 |
|
|
2024
Q1 | $552K | Sell |
33,270
-684
| -2% | -$11.4K | ﹤0.01% | 3574 |
|
|
2023
Q4 | $543K | Buy |
33,954
+891
| +3% | +$14.3K | ﹤0.01% | 3581 |
|
|
2023
Q3 | $2.52M | Buy |
33,063
+3,617
| +12% | +$275K | ﹤0.01% | 2989 |
|
|
2023
Q2 | $1.93M | Buy |
29,446
+19,785
| +205% | +$1.3M | ﹤0.01% | 3125 |
|
|
2023
Q1 | $578K | Buy |
9,661
+830
| +9% | +$49.6K | ﹤0.01% | 3586 |
|
|
2022
Q4 | $205K | Sell |
8,831
-19
| -0.2% | -$441 | ﹤0.01% | 4082 |
|
|
2022
Q3 | $296K | Buy |
8,850
+3,514
| +66% | +$118K | ﹤0.01% | 3997 |
|
|
2022
Q2 | $141K | Sell |
5,336
-6,780
| -56% | -$179K | ﹤0.01% | 4438 |
|
|
2022
Q1 | $356K | Buy |
12,116
+192
| +2% | +$5.64K | ﹤0.01% | 4115 |
|
|
2021
Q4 | $1.02M | Sell |
11,924
-143
| -1% | -$12.2K | ﹤0.01% | 3714 |
|
|
2021
Q3 | $898K | Buy |
12,067
+4,860
| +67% | +$362K | ﹤0.01% | 3737 |
|
|
2021
Q2 | $672K | Buy |
+7,207
| New | +$672K | ﹤0.01% | 3796 |
|